A pilot project offering COVID-19 vaccines in pharmacies is expanding more broadly starting Friday.
Some pharmacies in Toronto, Windsor and Kingston health units have already started offering Oxford-AstraZeneca vaccines to residents between the ages of 60 to 64.
Earlier this week, the province released the locations of more than 325 pharmacies that will be administering the Oxford-AstraZeneca vaccine.
Residents aged 60 to 64 as of the day of vaccination or if you will be or have been 60 to 64 in 2021, with the birth years 1957 to 1961, will be eligible to book an appointment with one of the pharmacies.
Shoppers Drug Mart, Loblaws, Rexall and Costco are among those who will be administering the vaccine along with some independent pharmacies.
Justin Bates of the Ontario Pharmacists’ Association says additional shots were to arrive on Thursday. That means vaccinations are set to begin at more sites on Friday.
Bates says interest in the pilot has been overwhelming.
Individual pharmacies are using their own booking systems and Bates says people should check online before calling due to high call volumes.
A portion of the AstraZeneca doses are also going to primary care physicians who will administer them to their patients in the regions of Hamilton, Toronto, Guelph, Peterborough, Simcoe-Muskoka, and Peel, starting on March 13.
Physicians won’t be taking appointments and will only be contacting their patients who are eligible.
The vaccine from AstraZeneca is the third approved in the county, but the National Advisory Committee on Immunization (NACI) is concerned there is limited data on how well the vaccine will work in older populations. The NACI is not recommending the shot for anyone over the age of 65.
Polio virus found in New York City wastewater, suggesting local transmission – CBC News
Health officials identified the virus that causes polio in New York City’s wastewater, suggesting local transmission of the virus, state authorities said on Friday, urging unvaccinated New Yorkers to get vaccinated.
“The NYC Heath Department and the New York State Department of Health have identified poliovirus in sewage in NYC,
suggesting local transmission of the virus,” the city’s health department said in a statement on Friday.
“Polio can lead to paralysis and even death. We urge unvaccinated New Yorkers to get vaccinated now.”
The identification comes weeks after a case of polio in an adult was made public on July 21 in Rockland County, marking the nation’s first confirmed case in nearly 10 years.
Earlier this month, health officials said the virus was found in wastewater in the New York City suburb a month before health officials there announced the Rockland County case.
The U.S. Centers for Disease Control and Prevention (CDC) said at the time that it was not clear whether the virus was actively spreading in New York or elsewhere in the United States.
Evidence of virus in London
There is no cure for polio, which can cause irreversible paralysis in some cases, but it can be prevented by a vaccine made available in 1955.
New York officials have said they are opening vaccine clinics to help unvaccinated residents get their shots.
Inactivated polio vaccine (IPV) is the only polio vaccine that has been given in the United States since 2000, according to the CDC. It is given by shot in the leg or arm, depending on the patient’s age.
On Wednesday, British health authorities announced they will offer a polio booster dose to children aged one to nine in London, after finding evidence the virus has been spreading in multiple regions of the capital. Britain’s Health Security Agency said polio virus samples were found in sewage water from eight boroughs of London, but there were no confirmed infections.
Polio is often asymptomatic and people can transmit the virus even when they do not appear sick. But it can produce
mild, flu-like symptoms that can take as long as 30 days to appear, officials said.
It can strike at any age but the majority of those affected are children aged three and younger.
Monkeypox: gov’t has no plans to call public health emergency – CTV News
Canada’s chief public health officer Dr. Theresa Tam says there are no plans at the moment to declare monkeypox a public health emergency.
While the World Health Organization and the United States have both recently done so, Tam said there is little benefit to declaring a federal public health emergency in Canada, because of the structure of regional and provincial public health authorities.
She said a federal emergency declaration would involve the Emergencies Act — which hasn’t even been invoked to address the nearly two-and-a-half-year COVID-19 pandemic in Canada. Tam said thus far, Canada has already been able to mobilize vaccines, therapeutics, and funding to tackle monkeypox.
Tam also said local and provincial authorities have more flexibility, and have been able to respond to the rise in monkeypox cases. Local and provincial authorities could also decide to declare the virus a public health emergency at those levels, as many did with COVID-19.
“To date our discussions have focused on testing, working with community organizations to raise awareness on ways to limit spread the virus, and deployment of the Imvamune vaccine and therapeutics,” Tam said. “As the global monkeypox outbreak continues to be a serious concern, focusing efforts on the impacted communities in Canada and worldwide, including with vaccinations, we have an opportunity to contain the spread.”
To day, approximately 99,000 doses of Imvamune have been deployed to the provinces and territories, and more than 50,000 people have been vaccinated, Tam said.
Canada’s Deputy Chief Public Health Officer Dr. Howard Njoo said the approach continues to be vaccinating higher risk communities first, and there are currently enough doses to do so.
Tam says there have been approximately 31,000 cases of monkeypox reported globally, with 1,059 in Canada, mostly in Ontario.
While cases of the virus first started popping up in Quebec, Ontario has since surpassed it in its number of infections.
To date, there have been 28 hospitalizations — two in intensive care — from monkeypox in Canada, and no deaths. Tam said it’s too soon to tell whether the number of cases has plateaued in Canada.
COVID-19 vaccine side-effects less likely in pregnant people, says study – CP24
Pregnant people experienced lower rates of side-effects from the COVID-19 vaccine than their counterparts who weren’t pregnant, a new Canadian study suggests.
The Canadian National Vaccine Safety Network collected data from 191,360 vaccinated women aged 15 to 49 between December 2020 and November 2021. The researchers asked participants to report “significant health events” that were serious enough to make them miss school or work, seek medical attention or disrupt their routines.
Of 5,597 pregnant participants, four per cent reported a significant health event within seven days of receiving their first dose of an mRNA vaccine, and 7.3 per cent of 3,108 pregnant respondents said they had side-effects from their second shots.
Among those who weren’t pregnant, 6.3 per cent of 174,765 respondents reported a significant health event after dose one, and 11.3 per cent of 10,254 participants said they felt sick after dose two.
“One of the things that was really striking was that the rates of these events happening in pregnant people was lower than the rates happening in non-pregnant people at the same age,” said Manish Sadarangani, lead author of the paper published in the Lancet Infectious Diseases journal on Thursday. “It’s very reassuring around the safety of COVID vaccines and pregnancy.”
Studies on other vaccines have found that pregnant people experience side-effects at roughly the same rate as those who aren’t pregnant or even slightly higher, said Sadarangani, an investigator at BC Children’s Hospital.
More research is needed to understand why this might not be the case for mRNA COVID-19 vaccines, Sadarangani said, but he suspects the physical transformation of pregnancy could be a factor.
“There’s a lot of hormonal and immunological and physiological changes happening during pregnancy, and some of them we understand, some of them we don’t,” he said. “I’m presuming that some of these changes are leading to these lower rates.”
Thursday’s study found that rates of serious health events after getting a COVID-19 vaccine, such as hospitalization, were similarly rare across all groups.
There was no significant difference in the rates of miscarriage or stillbirth among participants who were vaccinated and those who weren’t.
Researchers are conducting a followup survey to see if participants experienced any side-effects six months after their COVID-19 shots, Sadarangani said.
Pregnant people are at increased risk of COVID-19 complications, he said, so it’s all the more important that researchers continue to study how vaccination affects them and their babies.
“All of the data we have really highlight the safety of all of these vaccines in pregnancy,” said Sadarangani. “Ultimately, this is the best way to protect this group of people in our population.”
This report by The Canadian Press was first published Aug. 12, 2022.
Rogers, Shaw formalize planned Freedom sale to Quebecor – BNN Bloomberg
Women-owned NU Media marketing agency's founder attributes her business success to the passionate women of her team – Net Newsledger
Full moon may hinder most anticipated meteor shower of the year – DiscoverWestman.com
Silver investment demand jumped 12% in 2019
Europe kicks off vaccination programs | All media content | DW | 27.12.2020 – Deutsche Welle
Global Media Markets, 2015-2020, 2020-2025F, 2030F – TV and Radio Broadcasting, Film and Music, Information Services, Web Content, Search Portals And Social Media, Print Media, & Cable – GlobeNewswire
News9 hours ago
Alberta UCP membership drive and Heche on death’s door
News10 hours ago
Paddling to exorcism: Abuse allegations spark new regulations at Saskatchewan schools
News9 hours ago
Excitement in B.C. Indigenous communities as salmon get past Fraser slide zone
Politics24 hours ago
Politics Briefing: Canadian researchers and scientists march for better compensation – The Globe and Mail
Economy15 hours ago
Malaysian economy smashes forecasts, growing 8.9 percent in Q2 – Al Jazeera English
Health8 hours ago
Monkeypox: gov’t has no plans to call public health emergency – CTV News
Tech20 hours ago
Xiaomi Mix Fold 2 lands to battle Galaxy Z Fold 4, but you can't buy it – TrustedReviews
Tech7 hours ago
Xiaomi clones the Galaxy Fold, makes it 40% thinner, adds a bigger battery – Ars Technica